Vector Blog

Acetaminophen does not aggravate young children’s asthma

Your toddler is screaming in pain. Her forehead is burning. You rush to your local drugstore. What do you get — Tylenol or Motrin? And by the way, she also has asthma. Recently, many parents have been under the impression that acetaminophen (Tylenol, etc.) may do more harm than good in young children with asthma....

The post Acetaminophen does not aggravate young children’s asthma appeared first on Vector.

Citizen science: Genetic bone disease fuels a teen’s passion for research

When I was just 3 months old, I was diagnosed with fibular hemimelia, a rare genetic condition that affects about 1 in 50,000 people. It manifests itself as the lack of the fibula bone, a key structural bone in the lower leg that provides major stability in the ankle and knee. Fibular hemimelia leads to...

The post Citizen science: Genetic bone disease fuels a teen’s passion for research appeared first on Vector.

Who We are

The mission of the Technology and Innovation Development Office (TIDO) to maximize the impact of Boston Children’s innovations on patient health while enhancing the research endeavor.

News and Events

Fiscal Year 2015 was a year of growth at TIDO. Boston Children’s executed 48 licenses, a 42 percent increase over the prior year, while the total number of executed industry research and license agreements reached 91, an increase of 17 percent over the prior year. The report highlights selected agreements, Technology Development Fund award winners, and some of our technologies available for licensing.

The new IP Policy allows for researchers to independently generate and complete certain outbound academic MTAs if specific criteria are met. In addition, we have implemented a new form for initiating inbound MTAs. Please click the link above for instructions and to download the forms.

@ChildrensTIDO on Twitter

Connect with us

youtube

Terms and Conditions children's hospital
Site Designed and Developed by Genuine